Your browser doesn't support javascript.
loading
Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia.
Alhumaid, Saad; Al Mutair, Abbas; Al Alawi, Zainab; Al Salman, Khulud; Al Dossary, Nourah; Omar, Ahmed; Alismail, Mossa; Al Ghazal, Ali M; Jubarah, Mahdi Bu; Al Shaikh, Hanan; Al Mahdi, Maher M; Alsabati, Sarah Y; Philip, Dayas K; Alyousef, Mohammed Y; Al Brahim, Abdulsatar H; Al Athan, Maitham S; Alomran, Salamah A; Ahmed, Hatim S; Al-Shammari, Haifa; Elhazmi, Alyaa; Rabaan, Ali A; Al-Tawfiq, Jaffar A; Al-Omari, Awad.
Afiliação
  • Alhumaid S; Administration of Pharmaceutical Care, Alahsa Health Cluster, Ministry of Health, Rashdiah Street, P. O. Box 12944, Alahsa, 31982, Saudi Arabia. saalhumaid@moh.gov.sa.
  • Al Mutair A; Research Center, Almoosa Specialist Hospital, Alahsa, Saudi Arabia.
  • Al Alawi Z; School of Nursing, Wollongong University, Wollongong, Australia.
  • Al Salman K; College of Nursing, Princess Norah Bint Abdul Rahman University, Riyadh, Saudi Arabia.
  • Al Dossary N; Division of Allergy and Immunology, College of Medicine, King Faisal University, Alahsa, Saudi Arabia.
  • Omar A; Nursing Department, Al Jaber Hospital for Eye, Ear, Nose and Throat, Ministry of Health, Al-Hofuf, Saudi Arabia.
  • Alismail M; General Surgery Department, Alomran General Hospital, Alahsa, Saudi Arabia.
  • Al Ghazal AM; Internal Medicine Department, Alomran General Hospital, Alahsa, Saudi Arabia.
  • Jubarah MB; Pharmacy Department, King Faisal General Hospital, Alahsa, Saudi Arabia.
  • Al Shaikh H; Infection Prevention and Control Department, Prince Saud Bin Jalawi Hospital, Alahsa, Saudi Arabia.
  • Al Mahdi MM; Pharmacy Department, King Faisal General Hospital, Alahsa, Saudi Arabia.
  • Alsabati SY; Pharmacy Department, King Faisal General Hospital, Alahsa, Saudi Arabia.
  • Philip DK; Infection Prevention and Control Department, Prince Saud Bin Jalawi Hospital, Alahsa, Saudi Arabia.
  • Alyousef MY; Nursing Department, Maternity and Children Hospital, Alahsa, Saudi Arabia.
  • Al Brahim AH; Nursing Education Department, Maternity and Children Hospital, Alahsa, Saudi Arabia.
  • Al Athan MS; Administration of Academic Affairs and Research, Ministry of Health, Alahsa, Saudi Arabia.
  • Alomran SA; Pharmacy Department, King Fahad Hofuf Hospital, Alahsa, Saudi Arabia.
  • Ahmed HS; Planning and Research Department, Ministry of Health, Alahsa, Saudi Arabia.
  • Al-Shammari H; Pharmacy Department, King Fahad Hofuf Hospital, Alahsa, Saudi Arabia.
  • Elhazmi A; Planning and Research Department, Ministry of Health, Alahsa, Saudi Arabia.
  • Rabaan AA; Histopathology Department, King Saud Medical City, Riyadh, Saudi Arabia.
  • Al-Tawfiq JA; Intensive Care Unit Department, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.
  • Al-Omari A; Molecular Diagnostics Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Eur J Med Res ; 26(1): 47, 2021 May 24.
Article em En | MEDLINE | ID: mdl-34030733
ABSTRACT

BACKGROUND:

COVID-19 is a worldwide pandemic and has placed significant demand for acute and critical care services on hospitals in many countries.

OBJECTIVES:

To determine the predictors of severe COVID-19 disease requiring admission to an ICU by comparing patients who were ICU admitted to non-ICU groups.

METHODS:

A cohort study was conducted for the laboratory-confirmed COVID-19 patients who were admitted to six Saudi Ministry of Health's hospitals in Alahsa, between March 1, 2020, and July 30, 2020, by reviewing patient's medical records retrospectively.

RESULTS:

This cohort included 1014 patients with an overall mean age of 47.2 ± 19.3 years and 582 (57%) were males. A total of 205 (20%) of the hospitalized patients were admitted to the ICU. Hypertension, diabetes and obesity were the most common comorbidities in all study patients (27.2, 19.9, and 9%, respectively). The most prevalent symptoms were cough (47.7%), shortness of breath (35.7%) and fever (34.3%). Compared with non-ICU group, ICU patients had older age (p ≤ 0.0005) and comprised a higher proportion of the current smokers and had higher respiratory rates (p ≤ 0.0005), and more percentage of body temperatures in the range of 37.3-38.0 °C (p ≥ 0.0005); and had more comorbidities including diabetes (p ≤ 0.0005), hypertension (p ≥ 0.0005), obesity (p = 0.048), and sickle cell disease (p = 0.039). There were significant differences between the non-ICU and ICU groups for fever, shortness of breath, cough, fatigue, vomiting, dizziness; elevated white blood cells, neutrophils, alanine aminotransferase and alkaline aminotransferase, lactate dehydrogenase, and ferritin, and decreased hemoglobin; and proportion of abnormal bilateral chest CT images (p < 0.05). Significant differences were also found for multiple treatments (p < 0.05). ICU patients group had a much higher mortality rate than those with non-ICU admission (p ≤ 0.0005).

CONCLUSION:

Identifying key clinical characteristics of COVID-19 that predict ICU admission and high mortality can be useful for frontline healthcare providers in making the right clinical decision under time-sensitive and resource-constricted environment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Humans / Infant / Middle aged / Newborn País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Humans / Infant / Middle aged / Newborn País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article